A Phase III, Randomized, Open-label, Blinded Endpoint, Comparative Trial of Ferric Derisomaltose Versus no Intravenous Iron in Iron-deficient Subjects With Symptomatic Chronic Heart Failure
Clinical Focus
Practice Locations
Education
University of Michigan Medical Center
Medical SchoolUniversity of Kentucky College of Medicine
FellowshipUNC Hospitals
ResidencyDepartment of Emergency Medicine
Board Certifications
Certification Board of Cardiovascular Computed Tomography
Adult Comprehensive EchocardiographyNational Board of Echocardiography
Cardiovascular DiseaseAmerican Board of Internal Medicine
Internal MedicineAmerican Board of Internal Medicine
Hospital Affiliations
- Baptist Health Medical Group
- Baptist Health Paducah
Philosophy of Care
Research
A Randomized, Double-blind, Placebo-controlled Pragmatic Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure and Reduced Ejection Fraction Who Are Intolerant of or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
Combined Efficacy and Safety of an Early, Intensive, Management Strategy With Finerenone and SGLT2 Inhibitor in Patients Hospitalized With Heart Failure
Randomized Trial to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Heart Failure Patients With Left Ventricular Ejection Fraction Greater Than or Equal to 40% Hospitalized Due to an Episode of Acute Decompensated Heart Failure
Insurance
Our providers accept many insurance plans. Check the Baptist Health insurance policy to make sure yours is one of them.